Cell Therapy Market - By PMI

Cell Therapy Market, By Clinical-use, By Type, By Region - Trends, Analysis and Forecast till 2029

Prophecy Market Insights

The report "Cell Therapy Market, By Clinical-use (Therapeutic Area (Malignancies, Muscoskeletal Therapies, Autoimmune Disorders, Dermatology, and Others), Cell Type (Stem Cell Therapies, BM, Blood, & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, and Others), Non-stem Cell Therapies, and Research-use), By Type (Autologous Therapies and Allogenic Therapies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Key Highlights:

In December 2020, Bayer recently announced the launch of a cell and gene therapy platform (C>) within its pharmaceutical division. The platform will further consolidate its emerging leadership in the cell and gene therapy field and transform its overall business, the company said.

In July 2021, Ashfield, part of UDG Healthcare, has launched EmerGENE, a global end-to-end cell and gene therapy network approach designed to support small and midsize biotechs with the commercialization of their discoveries. EmerGENE has been built by a multidisciplinary team that delivers expert-led guidance and services to biotechs throughout their entire clinical to commercial journey.

In July 2021, Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its next-generation cell line development technology, GPEx Lightning. Leveraging Catalents proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx Lightning combines innovative technologies, including a novel gene insertion technology, to further shorten drug substance development by up to three months compared to previous timelines.

Analyst View:

The key driver driving global market growth is an increase in the occurrence of diseases such as cancer, cardiac problems, and others. In 2017, 9.6 million individuals died from various forms of cancer, according to data published by Our World in Data Organization in 2019. Furthermore, technical imrovements in the field of cell treatment, as well as the increased usage of human cells over animal cells for cell therapies research, are driving the global market forward. Government laws governing the use of cell therapy, on the other hand, may stifle worldwide market growth over the projection period. Nonetheless, the global market is likely to benefit from increased research funding and an increase in the number of policies promoting stem cell therapy in developing countries over the forecast period.

Request Free Sample: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3712

Report Scope:

1.Global Cell Therapy Market, By Clinical-use, 2019 2029, (US$ Bn) >Overview --Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 2029 --Y-o-Y Growth Analysis (%), 2019 2029 --Segment Trends >Therapeutic Area --Overview --Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 2029 --Malignancies --Muscoskeletal Therapies --Autoimmune Disorders --Dermatology --Others >Cell Type --Overview --Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 2029 --GTT Technology --96 System --Mark III System >Non-stem Cell Therapies >Research-use 5.Global Cell Therapy Market, By Type, 2019 2029, (US$ Bn) >Overview --Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 2029 --Y-o-Y Growth Analysis (%), 2019 2029 --Segment Trends >Autologous Therapies --Overview --Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 2029 >Allogenic Therapies --Overview --Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 2029

Key Market Insights from the report:

The Cell Therapy Market accounted for US$ 5.8 billion in 2020 and is estimated to be US$ 19.6 billion by 2030 and is anticipated to register a CAGR of 13.1%.

The Cell Therapy Market is segmented based on the Clinical-use, Type, and Region.

By Clinical-use, the Global Cell Therapy Market is segmented into Therapeutic Area (Malignancies, Muscoskeletal Therapies, Autoimmune Disorders, Dermatology, and Others), Cell Type (Stem Cell Therapies, BM, Blood, & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, and Others), Non-stem Cell Therapies, and Research-use.

By Type, the market is segmented into Autologous Therapies and Allogenic Therapies.

By Region, the Global Cell Therapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market in terms of market presence, followed by the European region with a significant market share due to the increasing demand for furnishings and dcor products that require minimum space.

Competitive Landscape: JCR Pharmaceuticals Co. Ltd. Kolon TissueGene MEDIPOST Osiris Therapeutics Stemedica Cell Technologies Cells for Cells NuVasive Anterogen.Co Fibrocell Science Vericel Corporation PHARMICELL Co., Ltd.

Regional scope:

North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

For More Information or Query or Customization before buying, Visit at: https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/3712

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Browse Other Related Research Reports from Prophecy Market Insights:

1.Cell Cryopreservation Market: By Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), By Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others), and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, Africa) - Trends, Analysis and Forecast till 2029

2.Cell Therapy Manufacturing Market: By Therapy Type (Allogeneic Cell Therapy and Autologous Cell Therapy) By Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, and 3D Technology), By Source (IPSCs, Bone Marrow, Umbilical Cord, Adipose Tissue, and Neural Stem Cells), By Application ( Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, and Other),and By Geography (North America, Latin America, Europe, Middle East, Asia Pacific, Africa) - Trends, Analysis and Forecast till 2029 Follow Us On: Linkedin | Twitter | Facebook

Shweta RProphecy Market Insights+1 860-531-2701email us hereVisit us on social media:FacebookTwitterLinkedIn

View post:
Cell Therapy Market is estimated to be US$ 19.6 billion by 2030 with a CAGR of 13.1% during the forecast - EIN News